Clinical course of liver injury induced by immune checkpoint inhibitors in patients with advanced malignancies
Takanori Ito(Aichi Medical University Hospital), Mitsuhiro Fujishiro(Bunkyo University), Yasuhiro Kodera(Nagoya Medical Center), Naoki Nishio(Nagoya University), Hidenori Toyoda(Ogaki Municipal Hospital), Michihiko Sone(Nagoya University), Satoshi Yasuda(Tohoku University), Tetsunari Hase(Nagoya University), Yoshie Shimoyama(Nagoya University Hospital), Hideharu Hibi(Nagoya University), Kazuyuki Mizuno(Nagoya University Hospital), Kenta Yamamoto(Teikyo Heisei University), Yoji Ishizu(Nagoya University), Naozumi Hashimoto(Nagoya University), Masatoshi Ishigami(Nagoya University), Hiroki Kawashima(Nagoya University Hospital), Norihiro Imai(Nagoya University), Osamu Maeda(Nagoya University Hospital), Kenji Yokota(International Research Center for Japanese Studies), Masashi Kato(Chubu University), Masashi Akiyama(Nagoya University), Takashi Honda(Osaka Hospital), Yuichi Ando(Nagoya University Hospital), Takafumi Yamamoto(Nagoya University)
Cited by 39
Related Papers
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
|Journal of Clinical Oncology|2014|2.8k
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
|New England Journal of Medicine|2017|2.2k
Genome sequencing and analysis of Aspergillus oryzae
|Nature|2005|1.3k
Revised nomenclature and classification of inherited ichthyoses: Results of the First Ichthyosis Consensus Conference in Sorèze 2009
|Journal of the American Academy of Dermatology|2010|793